[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Balloons Catheters - Medical Devices Pipeline Assessment, 2019

December 2019 | 195 pages | ID: P0CE8D9F3A61EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Balloons Catheters - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019' provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials

4 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOONS CATHETERS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development

5 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOONS CATHETERS COMPANIES AND PRODUCT OVERVIEW

5.1 3DT Holdings LLC Company Overview
  5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aachen Resonance GmbH Company Overview
  5.2.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.3 Acrostak (Schweiz) AG Company Overview
  5.3.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
5.4 AlviMedica Medical Technologies Inc Company Overview
  5.4.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Andramed GmbH Company Overview
  5.5.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.6 Atrium Medical Corp Company Overview
  5.6.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 B. Braun Interventional Systems Inc Company Overview
  5.7.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Bolton Medical Inc Company Overview
  5.8.1 Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Boston Scientific Corp Company Overview
  5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 BrosMed Medical Co., Ltd Company Overview
  5.10.1 BrosMed Medical Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Caliber Therapeutics Inc Company Overview
  5.11.1 Caliber Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Cardionovum GmbH Company Overview
  5.12.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.13 Concept Medical Inc Company Overview
  5.13.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Cordis Corp Company Overview
  5.14.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 CorNova Inc Company Overview
  5.15.1 CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Innovia LLC Company Overview
  5.16.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 iVascular SLU Company Overview
  5.17.1 iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview
5.18 Kaneka Corp Company Overview
  5.18.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  5.19.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Lithotech Medical Ltd Company Overview

6 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA) BALLOONS CATHETERS- RECENT DEVELOPMENTS

6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
6.3 Nov 07, 2019: Neovasc appoints cardiovascular industry Veteran Bill Little as Chief Operating Officer
6.4 Nov 07, 2019: Neovasc announces third quarter 2019 financial results
6.5 Nov 05, 2019: First round of late-breaking clinical trial results announced at VIVA19

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
Table 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
Table 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
Table 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Table 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials
Table 7: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development
Table 8: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Conductance Balloon Coronary Post-Dilatation Catheter - Product Status
Table 11: Conductance Balloon Coronary Post-Dilatation Catheter - Product Description
Table 12: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 13: VIAR - Product Status
Table 14: VIAR - Product Description
Table 15: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview
Table 16: PTCA Balloon - Product Status
Table 17: PTCA Balloon - Product Description
Table 18: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Fluydo - Product Status
Table 20: Fluydo - Product Description
Table 21: Invader CTO - Product Status
Table 22: Invader CTO - Product Description
Table 23: Invader PTCA Balloon Dilatation Catheter - Product Status
Table 24: Invader PTCA Balloon Dilatation Catheter - Product Description
Table 25: ProHP - Product Status
Table 26: ProHP - Product Description
Table 27: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Zero-Profile PTCA Balloon - Product Status
Table 29: Zero-Profile PTCA Balloon - Product Description
Table 30: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Coronary Stent Balloon Catheter - Product Status
Table 32: Coronary Stent Balloon Catheter - Product Description
Table 33: B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: SeQuent Please ReX Drug Coated PTCA Balloon Catheter - Product Status
Table 35: SeQuent Please ReX Drug Coated PTCA Balloon Catheter - Product Description
Table 36: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Flash PTCA - Product Status
Table 38: Flash PTCA - Product Description
Table 39: Runner PTCA Balloon Catheter - Product Status
Table 40: Runner PTCA Balloon Catheter - Product Description
Table 41: Runner Slim PTCA - Product Status
Table 42: Runner Slim PTCA - Product Description
Table 43: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 44: 1.2 Zulu PTCA - Product Status
Table 45: 1.2 Zulu PTCA - Product Description
Table 46: Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Status
Table 47: Agent Paclitaxel Coated-PTCA Balloon Catheter - Product Description
Table 48: NC Zulu PTCA Post-Dilatation Catheter - Product Status
Table 49: NC Zulu PTCA Post-Dilatation Catheter - Product Description
Table 50: Next Generation PCB - Product Status
Table 51: Next Generation PCB - Product Description
Table 52: Zulu PTCA Pre-Dilatation Catheter - Product Status
Table 53: Zulu PTCA Pre-Dilatation Catheter - Product Description
Table 54: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 55: Agent Paclitaxel Coated-PTCA Balloon Catheter - A 2:1 Randomized Trial Comparing the Agent Paclitaxel-coated PTCA Balloon Catheter Versus SeQuent Please Drug Eluting Balloon Catheter for the Treatment of a Small Vessel De Novo Native Coronary Artery Lesion
Table 56: Agent Paclitaxel Coated-PTCA Balloon Catheter - A Prospective Randomized Multicenter Non-inferiority Clinical Study to Determine the Safety and Performance of the Agent Paclitaxel-coated PTCA Balloon Catheter (Hemoteq) Compared to the SeQuent Please Paclitaxel-releasing Coronary Balloon Catheter (B.Braun) for the Treatment of Coronary In-stent Restenosis: AGENT-ISR
Table 57: BrosMed Medical Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Status
Table 59: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Description
Table 60: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Status
Table 61: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Description
Table 62: BrosMed Medical Co., Ltd - Ongoing Clinical Trials Overview
Table 63: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-dilatation of Stenosis and Occlusion in Patients with Symptomatic Ischemic Heart Disease

LIST OF FIGURES

Figure 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment
Figure 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory
Figure 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path
Figure 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Figure 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials

COMPANIES MENTIONED

3DT Holdings LLC
Aachen Resonance GmbH
Acrostak (Schweiz) AG
AlviMedica Medical Technologies Inc
Andramed GmbH
Atrium Medical Corp
B. Braun Interventional Systems Inc
Bolton Medical Inc
Boston Scientific Corp
BrosMed Medical Co., Ltd
Caliber Therapeutics Inc
Cardionovum GmbH
Concept Medical Inc
Cordis Corp
CorNova Inc
Innovia LLC
iVascular SLU
Kaneka Corp
Lifetech Scientific (Shenzhen) Co Ltd
Lithotech Medical Ltd
Medix Innovators Inc.
Medtronic plc
Meril Life Sciences Pvt Ltd
MicroPort Scientific Corp
Natec Medical Ltd
OrbusNeich
Orchestra BioMed Inc
QT Vascular Ltd
QualiMed Innovative Medizinprodukte GmbH
Sahajanand Medical Technologies Pvt Ltd
SIS Medical AG
Spectranetics Corp
Vascular Nanotransfer Technologies
VasoTech Inc.


More Publications